This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

William Hudson
Washington +1 202 662 5757 Download V-card

William Hudson specializes in the regulation of pharmaceutical products and biotechnology. He counsels clients on compliance with state and federal regulatory regimes, especially those of the Food and Drug Administration. Mr. Hudson also provides advice and regulatory due diligence to support the corporate transactions of the firm’s life sciences clients.

Mr. Hudson is a member of the Bar of California. District of Columbia bar application is pending; supervised by principals of the firm.

  • Co-authored a successful Regenerative Medicine Advanced Therapy (RMAT) designation request for a biopharma company, securing accelerated review by the FDA.
  • Advised clients on the labeling, marketing, and promotion of FDA-regulated products.
  • Advised pharmaceutical companies on international pharmacovigilance requirements.
  • Conducted regulatory due diligence for acquisition of clinical-stage company.
  • Advised company on granting “expanded access” to unapproved drug product.
  • Represented state agency in an appeal of a Medicaid disallowance related to the collection of alleged overpayments before the HHS Departmental Appeals Board.

Pro Bono

  • Fedora v. Merit Systems Protection Board (U.S. Supreme Court) (Co-authored amici curiae brief in support of veteran’s cert petition).

Previous Experience

  • U.S. Food and Drug Administration, Office of Policy, Intern (2015)
  • CNN, Producer (2008-2014)
  • National Headliner Award Winner, Environmental Reporting, Press Club of Atlantic City (2012)